Trials / Completed
CompletedNCT02247947
Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Universitätsklinikum Köln · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Proteomics is used to identify prognostic markers after CPR. Additionally neurological outcome should be estimated by specific protein alterations and affections of pathways.
Detailed description
Proteomics is used to identify prognostic markers after CPR, i.e. altered proteins on a 2G-gel. Additionally neurological outcome should be estimated by specific protein alterations and affections of pathways.
Conditions
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2020-11-01
- Completion
- 2020-11-01
- First posted
- 2014-09-25
- Last updated
- 2020-11-04
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02247947. Inclusion in this directory is not an endorsement.